Q&A

Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...

Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....

In this expert Q&A, lead study author Hyon K. Choi, MD, DrPH, discusses his team's study examining the association between serum urate levels and the rate of recurrent gout flares among patients with a...

In this Q and A, Valentina Celoria, MD, discusses the relationship between the human microbiome and psoriatic disease, as well as what this relationship may mean for future treatments.

Jennifer Walsh, DNP, CPNP, CNE talks about the reasons for the sudden surge in measles cases in the United States, what clinicians can do to make their patients aware of the increase, and the potential...

In this Q and A, Nader Shaik, MD, MPH, discusses the results of his team's recent study examining treatment failure rates of short-course vs standard-course antimicrobial therapy for the treatment of...

In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...

In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.

In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.

In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...